BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, May 15, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Regulatory actions for Sept. 7, 2021

Sep. 7, 2021
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Medtronic, Siemens Healthineers, Transmedics.
Read More

Other news to note for Sept. 7, 2021

Sep. 7, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Active Implants, Antylia Scientific, Avantor, Cardiogenics, Covidgenic, Dnanudge, Fresenius Helios, Geistlich Pharma, Inanobio, Innovative Medical Engineering Technologies, Masterflex Bioprocessing, Natera, NRG Oncology, Vivolta.
Read More

In the clinic for Sept. 7, 2021

Sep. 7, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Masimo, Medtronic, Nuprobe.
Read More

Financings for Sept. 7, 2021

Sep. 7, 2021
Med-tech firms raising money in public or private financings, including: Definitive Healthcare, Emulate, Hancock Jaffe Laboratories, Windgap Medical.
Read More

Appointments and advancements for Sept. 7, 2021

Sep. 7, 2021
New hires and promotions in the med-tech industry, including: Concert AI, Discovery Life Sciences, Screenpoint Medical, Vericel.
Read More

Holiday notice

Sep. 7, 2021
BioWorld's offices were closed in observance of Labor Day in the U.S. No issue was published Monday, Sept. 6.
Read More
Pathfinder photo

Neptune device to stop looping during GI procedures receives FDA clearance

Sep. 3, 2021
By Annette Boyle

Multiple sizes of Neptune Medical LLC’s overtube for gastrointestinal (GI) procedures that allows thin-walled tubes to toggle between flexible and rigid states received FDA clearance. With the clearance, the Burlingame, Calif.-based company now has nine sizes of cleared single-use overtubes with more in the wings. The Pathfinder endoscope overtube device uses Neptune’s Dynamic Rigidization technology to keep tubes from looping during procedures, a problem that leads to procedure failure, patient pain and complications in colonoscopy and other GI procedures.


Read More
DNA illustration

NIH collaborates on test predictive of peripheral nerve sheath tumor occurrence

Sep. 3, 2021
By Mark McCarty
The U.S. National Institutes of Health had its hands full with the Rapid Acceleration of Diagnostics (RADx) program as the COVID-19 pandemic unwound, but the agency’s other work on diagnostics is bearing fruit. NIH said Aug. 31 that its collaboration with an academic research institute has led to development of a test that predicts which patients suffering from neurofibromatosis will develop cancers with metastatic potential.
Read More
Money sack with British pound symbol

Orthobiologics startup Locate Bio seals £10M deal to scale clinical studies

Sep. 3, 2021
By Catherine Longworth
Locate Bio Ltd. has closed a £10 million (US$13.8 million) funding round co-led by investors Mercia Asset Management and BGF to advance its orthobiologics product pipeline. The Nottingham, U.K.-based startup, which spun out from the University of Nottingham’s School of Pharmacy, is hoping to disrupt the orthobiologics market with its drug releasing, bone grafting products.
Read More
IPO puzzle pieces

Following A$90M IPO, Trajan doubles share price as it executes global strategy

Sep. 3, 2021
By Tamra Sami
PERTH, Australia – On the heels of a A$90 million (US$67.12 million) initial public offering on the Australian Securities Exchange, device company Trajan Group Holdings Ltd. has doubled its share price and is well poised for its next stage of global growth. Trajan makes precision consumable products, devices and solutions that used in analyzing biological samples.
Read More
Previous 1 2 … 1106 1107 1108 1109 1110 1111 1112 1113 1114 … 10247 10248 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 15, 2026.
  • Illustration of a glowing circle to represent circRNA

    ASGCT 2026: Circular RNA, the new beast in gene and cell therapy

    BioWorld
    Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
  • Brain maze

    Alzheimer’s, beyond the brain

    BioWorld
    Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
  • Test tubes, dropper and capsules

    Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal

    BioWorld
    In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 12, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing